Training | 2021.12.21
Vuja De Sciences Announces Appointment of Translational Medicine and Cancer Metastasis Research Pioneer to Board of Directors.
New board member brings extensive experience in elucidating the biology of metastatic cancer progression and leading translational medicine approaches at the National Cancer Institute and at leading large pharma.
(PRWeb December 21, 2021)
Read the full story at https://www.prweb.com/releases/vuja_de_sciences_announces_appointment_of_translational_medicine_and_cancer_metastasis_research_pioneer_to_board_of_directors/prweb18403917.htm
For more information, please visit
https://www.prweb.com/releases/vuja_de_s[...]of_directors/prweb18403917.htm
